BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1365 related articles for article (PubMed ID: 12897487)

  • 41. [Spinal fusion of lumbar intertransverse process by using tissue engineered bone with xenogeneic deproteinized cancellous bone as scaffold].
    Gao C; Li Q; Jian Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Feb; 21(2):115-9. PubMed ID: 17357455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lower dose of rhBMP-2 achieves spine fusion when combined with an osteoconductive bulking agent in non-human primates.
    Barnes B; Boden SD; Louis-Ugbo J; Tomak PR; Park JS; Park MS; Minamide A
    Spine (Phila Pa 1976); 2005 May; 30(10):1127-33. PubMed ID: 15897825
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Osteogenic protein versus autologous interbody arthrodesis in the sheep thoracic spine. A comparative endoscopic study using the Bagby and Kuslich interbody fusion device.
    Cunningham BW; Kanayama M; Parker LM; Weis JC; Sefter JC; Fedder IL; McAfee PC
    Spine (Phila Pa 1976); 1999 Mar; 24(6):509-18. PubMed ID: 10101812
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model.
    Miyazaki M; Zuk PA; Zou J; Yoon SH; Wei F; Morishita Y; Sintuu C; Wang JC
    Spine (Phila Pa 1976); 2008 Apr; 33(8):863-9. PubMed ID: 18404105
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery.
    Steffen T; Stoll T; Arvinte T; Schenk RK
    Eur Spine J; 2001 Oct; 10 Suppl 2(Suppl 2):S132-40. PubMed ID: 11716010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. rhBMP-2 (ACS and CRM formulations) overcomes pseudarthrosis in a New Zealand white rabbit posterolateral fusion model.
    Lawrence JP; Waked W; Gillon TJ; White AP; Spock CR; Biswas D; Rosenberger P; Troiano N; Albert TJ; Grauer JN
    Spine (Phila Pa 1976); 2007 May; 32(11):1206-13. PubMed ID: 17495777
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Heterotopic osteogenesis of autogenous marrow stromal cells on ceramic bovine bone/ hydrogel scaffold].
    He D; Jin Y; Luo K; Li S
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Feb; 20(2):116-20. PubMed ID: 16529318
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A bioactive and bioresorbable porous cubic composite scaffold loaded with bone marrow aspirate: a potential alternative to autogenous bone grafting.
    Tanaka K; Takemoto M; Fujibayashi S; Neo M; Shikinami Y; Nakamura T
    Spine (Phila Pa 1976); 2011 Mar; 36(6):441-7. PubMed ID: 21124263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What bone graft substitutes should we use in post-traumatic spinal fusion?
    Guerado E; Fuerstenberg CH
    Injury; 2011 Sep; 42 Suppl 2():S64-71. PubMed ID: 21839997
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mixing conditions for cell scaffolds affect the bone formation induced by bone engineering with human bone marrow stromal cells, beta-tricalcium phosphate granules, and rhBMP-2.
    Uchida M; Agata H; Sagara H; Shinohara Y; Kagami H; Asahina I
    J Biomed Mater Res A; 2009 Oct; 91(1):84-91. PubMed ID: 18767063
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The safety and efficacy of OP-1 (rhBMP-7) as a replacement for iliac crest autograft for posterolateral lumbar arthrodesis: minimum 4-year follow-up of a pilot study.
    Vaccaro AR; Whang PG; Patel T; Phillips FM; Anderson DG; Albert TJ; Hilibrand AS; Brower RS; Kurd MF; Appannagari A; Patel M; Fischgrund JS
    Spine J; 2008; 8(3):457-65. PubMed ID: 17588821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion.
    Minamide A; Yoshida M; Kawakami M; Yamasaki S; Kojima H; Hashizume H; Boden SD
    Spine (Phila Pa 1976); 2005 May; 30(10):1134-8. PubMed ID: 15897826
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ceramic granules enhanced with B2A peptide for lumbar interbody spine fusion: an experimental study using an instrumented model in sheep.
    Cunningham BW; Atkinson BL; Hu N; Kikkawa J; Jenis L; Bryant J; Zamora PO; McAfee PC
    J Neurosurg Spine; 2009 Apr; 10(4):300-7. PubMed ID: 19441986
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: emphasis of surgical exploration and histologic assessment.
    Kanayama M; Hashimoto T; Shigenobu K; Yamane S; Bauer TW; Togawa D
    Spine (Phila Pa 1976); 2006 May; 31(10):1067-74. PubMed ID: 16648739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. rhBMP-2 enhancement of posterolateral spinal fusion in a rabbit model in the presence of concurrently administered doxorubicin.
    Singh K; Smucker JD; Ugbo JL; Tortolani PJ; Tsai L; Fei Q; Kuh S; Rumi M; Heller JG; Boden SD; Yoon ST
    Spine J; 2007; 7(3):326-31. PubMed ID: 17482116
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of nano-hydroxyapatite/collagen composite and bone morphogenetic protein-2 on lumbar intertransverse fusion in rabbits.
    Sun TS; Guan K; Shi SS; Zhu B; Zheng YJ; Cui FZ; Zhang W; Liao SS
    Chin J Traumatol; 2004 Feb; 7(1):18-24. PubMed ID: 14728813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of lentiviral gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats.
    Miyazaki M; Sugiyama O; Tow B; Zou J; Morishita Y; Wei F; Napoli A; Sintuu C; Lieberman JR; Wang JC
    J Spinal Disord Tech; 2008 Jul; 21(5):372-9. PubMed ID: 18600149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vivo evaluation of calcium sulfate as a bone graft substitute for lumbar spinal fusion.
    Glazer PA; Spencer UM; Alkalay RN; Schwardt J
    Spine J; 2001; 1(6):395-401. PubMed ID: 14588295
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2.
    Burkus JK; Transfeldt EE; Kitchel SH; Watkins RG; Balderston RA
    Spine (Phila Pa 1976); 2002 Nov; 27(21):2396-408. PubMed ID: 12438990
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and beta-tricalcium phosphate in a rabbit model.
    Namikawa T; Terai H; Suzuki E; Hoshino M; Toyoda H; Nakamura H; Miyamoto S; Takahashi N; Ninomiya T; Takaoka K
    Spine (Phila Pa 1976); 2005 Aug; 30(15):1717-22. PubMed ID: 16094272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.